贵州三力(603439) - 2020 Q3 - 季度财报

Financial Performance - Operating revenue for the first nine months was ¥363,575,605.42, down 36.38% from ¥571,454,686.61 in the same period last year[18] - Net profit attributable to shareholders of the listed company was ¥48,649,348.20, a decrease of 48.28% compared to ¥94,064,090.95 in the previous year[18] - Basic earnings per share decreased by 53.85% to ¥0.12 from ¥0.26 in the same period last year[20] - Total revenue for Q3 2020 was ¥81,656,124.72, a decrease of 63.5% compared to ¥223,409,726.51 in Q3 2019[54] - Operating profit for Q3 2020 was ¥2,249,392.94, down 95.1% from ¥45,857,802.90 in Q3 2019[57] - Net profit for Q3 2020 was ¥2,170,517.66, a decline of 94.4% compared to ¥38,973,853.81 in Q3 2019[57] - The company reported a net profit of CNY 281,998,428.16, compared to CNY 233,349,079.96, reflecting a growth of 20.9%[46] Assets and Liabilities - Total assets at the end of the reporting period reached ¥1,095,576,308.25, an increase of 49.91% compared to the end of the previous year[18] - Total liabilities rose to CNY 159,002,421.92 from CNY 79,721,306.69, marking a 99.5% increase[46] - Current assets totaled CNY 919,011,778.78 as of September 30, 2020, up from CNY 552,110,800.90 on December 31, 2019, representing a 66.4% increase[46] - Total equity attributable to shareholders increased to CNY 936,589,312.39 from CNY 651,098,964.19, reflecting a growth of 43.9%[46] - The company reported a total asset value of CNY 1,095,576,308.25, up from CNY 730,806,442.77, indicating a 49.8% increase[46] Cash Flow - Cash flow from operating activities for the first nine months was ¥38,336,632.26, down 50.01% from ¥76,695,521.75 in the previous year[18] - Cash inflow from financing activities totaled CNY 461,508,377.83, with a net cash flow of CNY 338,387,290.10 after outflows[65] - Net cash flow from operating activities for the first three quarters of 2020 was CNY 38,336,632.26, down from CNY 76,695,521.75 in 2019, indicating a decline of approximately 50%[63] - Total cash inflow from operating activities was CNY 427,732,423.72, down from CNY 595,410,807.13 in 2019, reflecting a decrease of approximately 28%[63] - Total cash outflow from operating activities was CNY 389,395,791.46, compared to CNY 518,715,285.38 in the same period of 2019, showing a reduction of about 25%[63] Shareholder Information - The total number of shareholders at the end of the reporting period was 20,492[26] - Major shareholder Zhang Hai holds 46.32% of the shares, with 20,000,000 shares pledged[26] Research and Development - Research and development expenses increased by 48.48% to CNY 2,942,667.08, reflecting a focus on new drug development projects[34] - Research and development expenses for Q3 2020 were ¥2,324,418.85, significantly higher than ¥145,668.47 in Q3 2019, indicating a focus on innovation[54] Government Support - The company received government subsidies of ¥99,742.00 related to stable employment during the reporting period[22] Market Strategy - The company aims to enhance market expansion and product development strategies in the upcoming quarters[56]